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ABSTRACT 26 
Alpha-actinin-3 (ACTN3) is an integral part of the Z-line of the sarcomere. The ACTN3 R577X 27 
(rs1815739) polymorphism determines the presence or absence of functional ACTN3 which may 28 
influence the extent of exercise induced muscle damage. This study aimed to compare the impact of, 29 
and recovery from, muscle-damaging eccentric exercise on subjects with or without functional alpha-30 
actinin-3. Seventeen young men (20-33 years), homozygous for the R- (n=9) or X- (n=8) alleles, 31 
performed two bouts of stretch–shortening exercise (50 drop jumps) 2 weeks apart. Muscle soreness, 32 
plasma creatine kinase (CK) activity, jump height, maximal voluntary isometric torque (MVC), peak 33 
concentric isokinetic torque (IT), and electrically stimulated knee extension torques at 20 Hz and at 34 
100 Hz were measured at baseline and a number of timepoints up to 14 days after each bout. There 35 
were no significant baseline differences between the groups. However, significant 36 
timepoint*genotype interactions were observed for MVC (p=0.021) and IT (p=0.011) for the 37 
immediate effect of eccentric exercise in bout 1. The RR group showed greater voluntary force 38 
decrements (RR v XX, MVC: -33.3% v -24.5%, IT: -35.9% v -23.2%) and slower recovery. A 39 
repeated bout effect was clearly observed but there were no differences by genotype group. ACTN3 40 
genotype modulates the response of muscle function to plyometric jumping exercise, although the 41 
differences are modest. ACTN3 genotype does not influence the clearly observed repeated bout 42 
effect; however, XX homozygotes recover baseline voluntary torque values faster and thus may be 43 
able to undertake more frequent training sesssions. 44 
 45 
Keywords: Alpha-actinin-3; R577X genoptye; eccentric exercise; muscle damage; repeated bout 46 
effect; elite athletes. 47 
 48 
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INTRODUCTION 50 
Muscles are used to both drive movement (concentric contractions) and to act as breaks to 51 
movement (eccentric contractions). Vigorous exercise of any description can result in muscle 52 
damage (Clarkson et al. 1986); however, the most severe muscle damage is caused by unaccustomed 53 
eccentric exercise (Newham et al. 1983), that is when contracting muscles are actively lengthening. 54 
Such eccentric contractions are common during sport and are of importance because the ensuing 55 
muscle damage has been associated with muscle weakness, strains and injury (Proske et al. 2004). 56 
Eccentric contractions rarely occur in isolation in natural movements and are typically followed by a 57 
concentric action in what is known as the stretch–shortening cycle (Byrne et al. 2004). This has also 58 
been shown to elicit muscle damage, can result in severe stiffness and soreness of muscles, 59 
sarcomeric disruption and a reduction in peak isometric force for several days after an exercise bout 60 
(Byrne et al. 2004). Understanding the underlying contributors to this phenomenon will help to 61 
understand muscle function and have implications for the design of exercise programmes. 62 
Interestingly, a second bout of eccentric exercise within days or weeks of the initial muscle 63 
damaging bout elicits markedly reduced symptoms of muscle damage compared with those 64 
experienced after the initial bout (Clarkson et al. 1992). This phenomenon, known as the repeated 65 
bout effect, is observed in both humans and animals (Mchugh 2003) although the underlying 66 
mechanisms remain to be fully elucidated. Neural adaptation to the initial exercise bout may be 67 
involved (Warren et al. 2000), however, the repeated bout effect has been demonstrated with 68 
electrically stimulated contractions in human elbow flexors (Nosaka et al. 2002), indicating that 69 
adaptations can occur independently of changes in central activation. Other hypotheses that have 70 
been suggested focus primarily on subcellular structural adaptations such as: increased collagen 71 
content (Lapier et al. 1995); increased serial sarcomere number (Butterfield et al. 2005; Butterfield & 72 
Herzog 2006; Lynn et al. 1998); and, increased desmin content (Barash et al. 2002; Peters et al. 73 
2003). 74 
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It has been postulated that the sarcomeric disruption caused by eccentric exercise may drive 75 
the reduction in muscle functional capacity associated with eccentric exercise (Proske et al. 2004). 76 
Inter-individual differences in the vulnerability of muscle tissue to exercise induced damage may be 77 
in part genetically determined by variation in genes such as alpha-actinin-3 (ACTN3). ACTN3 both 78 
anchors myofibrillar actin filaments to the Z-line in type II (fast) muscle fibers and is also implicated 79 
in metabolic and signalling pathways through its interaction with many types of protein (Lek et al. 80 
2010; Mills et al. 2001). It is of interest here primarily because of its structural role in the sarcomere 81 
and a common nonsense polymorphism, R577X (rs1815739), which results in the complete absence 82 
of the protein in ~16% of the global human population (North et al. 1999). These XX homozygotes 83 
are, however, outwardly healthy due to functional redundancy with Alpha-actinin-2 (ACTN2) (North 84 
et al. 1999), although genotype associations with sprinting speed (Alfred et al. 2011; Moran et al. 85 
2007; Yang et al. 2003) and strength (Walsh et al. 2008) show that the redundancy is incomplete.  86 
There are a limited number of conflicting reports in the literature on ACTN3 and eccentric 87 
muscle damage (Clarkson et al. 2005; Norman et al. 2009; Vincent et al. 2010); here we aimed to 88 
provide a detailed assessment of muscle function before and after two bouts of muscle damaging 89 
exercise, two weeks apart, to highlight associations of genotype with differences in muscle damage, 90 
or function, and the repeated bout effect. We assessed jump height, a practical measure of muscle 91 
function, and both maximal voluntary (MVC, maximal voluntary contraction; and IT, isokinetic peak 92 
torque) and involuntary (P20, electrically stimulated knee extension torque at 20 Hz; and P100, 93 
electrically stimulated knee extension torque at 100 Hz) contractions to allow differentiation between 94 
maximal and submaximal stimulation of muscles. Muscle strength loss has previously been shown to 95 
be a more reliable indicator of muscle damage than muscle soreness or increases in plasma protein 96 
activity (Warren et al. 1999). We also assessed changes in both perceived extent of muscle damage 97 
(muscle soreness) and biochemical markers (plasma CK activity). 98 
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If R577X polymorphism influences the response to initial and / or repeated bouts of stretch-99 
shortening exercise, its effects may be tested with the following hypotheses: firstly, due to ACTN3’s 100 
structural role, that XX homozygotes may show an increased vulnerability to muscle damaging 101 
exercise in one or both bouts; secondly, due to its involvement in intracellular signalling, that the 102 
time over which indicators of such damage persist may be altered in the XX group in one or both 103 
bouts; and finally, that any changes between the repeated bouts in the extent or duration of damage, 104 
may be altered in the XX group. This would provide evidence that ACTN3 genotype could account 105 
for inter-individual differences in the plasticity of skeletal muscles. 106 
107 
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MATERIALS AND METHODS 108 
Ethical Approval 109 
The study was approved by the Lithuanian State Ethics Committee and is consistent with the 110 
principles outlined in the Declaration of Helsinki. Each subject read and signed a written informed 111 
consent form prior to participation. 112 
Subjects 113 
Eighteen healthy young men were recruited from a larger ongoing association study based on 114 
their ACTN3 R577X genotype. This allowed selection of genotype groups of equal size (n=9). Only 115 
subjects homozygous for the R-allele (i.e. with a complete complement of ACTN3), or subjects 116 
homozygous for the X-allele (i.e. complete absence of ACTN3) were selected to take part. This was 117 
intended to provide the largest power to detect differences between genotype groups. One subject 118 
dropped out before completion of the study and was removed from all analyses. Subjects were 119 
moderately physically active (< 2 h/wk) but did not take part in any regular physical exercise 120 
program. They were asked to maintain their normal routine and refrain from any strenuous exercise 121 
for one month prior to, and throughout the duration of, the study. Subjects with any existing medical 122 
condition or taking medication that could affect natural muscle mass or function were excluded from 123 
the study. Subjects were also asked to refrain from taking any pain medication during the trial. 124 
Genotyping 125 
DNA was extracted from blood samples using the NucleoSpin
®
 Blood kit (Macherey-Nagel, 126 
GmbH & Co KG, Düren, Germany) according to the manufacturer‘s protocol. ACTN3 R577X 127 
genotype was determined using a PCR-RFLP method described in detail in the supplementary 128 
section of (Moran et al. 2007). Briefly, the primer sequences were 5’-129 
CTGGGCTGGAAGACAGGAG-3' (forward) and 5’-AGGGTGATGTAGGGATTGGTG-3' 130 
(reverse). The 290 bp amplification product was digested with DdeI restriction enzyme (New 131 
England Biolabs UK Ltd., Hitchin, Hertfordshire, UK) and separated on a 2% agarose gel.  RR 132 
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homozygotes remained uncut; XX homozygotes had a single DdeI site and migrated as 192 bp and 133 
98 bp bands. Subjects with RR or XX genotypes were recruited into the study. 134 
Familiarisation and Warm Ups 135 
A familiarisation session was performed one week before the initial drop jump bout (Table 136 
1). Subjects were seated in the isokinetic dynamometer chair and asked to maximally activate their 137 
knee extensor muscles, and then to perform five submaximal drop jumps. Their psychological 138 
tolerance to electrical stimulation was assessed. All participants showed good compliance with the 139 
procedure. 140 
A wam-up preceded all test sessions. It comprised 6–8 min of stationary cycling with the 141 
power set so that the Watts were approximately equal to the subject’s body weight (kg), followed by 142 
some light stretching exercises. 143 
Muscle Damaging Exercise 144 
Two drop jump bouts, separated by two weeks, were performed (Table 1). Fifty drop jumps 145 
(with arms akimbo) were performed in each bout. Each drop jump comprised a jump from a 40 cm 146 
elevation to a squat of 90° at the knee joints, followed immediately by a maximal counter-movement 147 
vertical jump. A rest period of 20 s between jumps was chosen to minimise changes in energy 148 
metabolites that could affect muscle function (Vollestad et al. 1988). This protocol has previously 149 
been shown to cause measurable levels of muscle damage (Miyama & Nosaka 2007). 150 
 Muscle Functional Assessments 151 
Muscle contractile properties were recorded before and immediately after (within 2–5 152 
minutes) each drop jump bout then 2, 7, and 14 days into the recovery (Table 1) in the following 153 
order: P20, P100, MVC, IT, and five maximal drop jumps. 154 
Since maximal effort was used to jump vertically after each of the drop jumps and this was 155 
performed on a contact mat (Newtest Powertimer Testing System, Oulu, Finland), the height of this 156 
jump (cm) was calculated with the formula: jump height = 122.625  (Tf)
2
, where Tf = flight time (s) 157 
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(Bosco et al. 1982). To obtain a robust estimate of jump height, the average height of five 158 
consecutive jumps was used for further analysis. 159 
Measurements of voluntary and elecitrically stimulated torque were made on an isokinetic 160 
dynamometer (System 3; Biodex Medical Systems, Shirley, New York) calibrated according to the 161 
manufacturer’s service manual with a correction for gravity performed using the Biodex Advantage 162 
program (version 3.0). There was a 2 minute rest period between the electrically stimulated and 163 
voluntary contractions. The coefficient of variation for involuntary and voluntary torques over 164 
repeated tests was <5%. 165 
MVC was measured at 120° knee angle (where 180° is full knee extension). Subjects were 166 
instructed to achieve and maintain maximal efforts of knee extension for 2–3 s. Each trace was 167 
visually inspected to ensure that there were no artefactual spikes at the start of the signal curve. 168 
Concentric IT of the knee extensors was measured at 30°s
-1
 (range of motion from 75° to 160°). IT at 169 
30°s
-1
 produces similar results to MVC, but allows for differences in optimal force production angle 170 
(Kannus & Beynnon 1993; Skurvydas et al. 2010). Briefly, subjects were asked to extend their knee 171 
with maximal effort through the full range of motion, then relax and let their leg return to a neutral 172 
position (~90° knee angle). Arms were crossed on the chest (hands grasping the trunk supporting 173 
belts) during all tests on the dynamometer. To help ensure a maximal effort, standard vocal 174 
encouragement was provided during each jump and voluntary knee extension trial by the same 175 
experienced investigator. The subjects were asked to perform three attempts of each mode with a rest 176 
interval of 1 min. Only the best attempt was recorded. The highest peak torque attained in each mode 177 
and the knee angle at which peak torque was attained were recorded.  178 
The equipment and procedure for electrically stimulated torque have been described 179 
previously (Skurvydas et al. 2010). Briefly, muscle stimulation was applied using flexible surface 180 
electrodes (MARP Electronic, Krakow, Poland) with one electrode (6  20 cm) placed transversely 181 
across the width of the proximal portion of the quadriceps femoris next to the inguinal ligament and 182 
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the other electrode (6  11 cm) covering the distal portion of the muscle above the patella. A 183 
constant current electrical stimulator (MG 440; Medicor, Budapest, Hungary) was used to deliver 1 184 
ms square-wave pulses at 150 V. Peak torques induced by a 1 s electrical stimulation at 20 Hz (P20; 185 
representing the steep section of the force-frequency relationship curve) and 100 Hz (P100; which is 186 
close to maximal force) were measured with the knee at 120° with a 3 s rest interval between 187 
electrical stimulations. Previous studies in humans have shown that eccentric contractions tend to 188 
affect muscle force more at low frequency (e.g. 20 Hz) than at high frequency (e.g. 100 Hz) 189 
stimulation and 20 and 100 Hz have previously been used in this context by others (Jones 1996). The 190 
change in the P20 to P100 ratio was used as a proxy for low-frequency fatigue (Jones 1996; 191 
Ratkevicius et al. 1998; Skurvydas et al. 2011). 192 
Muscle Soreness and Plasma CK Assessments 193 
Muscle soreness was reported subjectively daily throughout the study using an ordinal scale 194 
of 0-10, where 0 represented “no pain” and 10 represented “intolerably intense pain” (Ratkevicius et 195 
al. 1998). Participants rated the severity of soreness in their quadriceps when performing 2–3 squats 196 
just before the bout 1, and then daily at the same time of day, starting 24 h after the drop jump bout. 197 
Percentages for muscle soreness could not be calculated as all baseline values were zero. Therefore, 198 
raw muscle soreness data were used for analyses. 199 
Samples of venous blood were collected, immediately centrifuged and analysed for plasma 200 
CK activity (µkat∙L–1) using a SpotchemTM EZ SP-4430 biochemical analyser (Menarini Diagnostics, 201 
Reading, UK) with soft reagent strips (ArkRay Factory Inc., Shiga, Japan). Samples for CK activity 202 
were collected at baseline and 48 h, 1 week and 2 weeks after each exercise bout. 203 
Statistical Analysis 204 
Initial baseline values, for all phenoptyes, were normally distributed by the Ryan-Joiner test 205 
(Minitab 16.1.0). Baseline differences were assessed using unpaired t-tests. For repeated measures 206 
analyses, data (except for muscle soreness) were expressed as a percentage of bout-specific baseline 207 
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values to account for baseline and bout variation. Prior to analyses, data were tested for normaility 208 
using the Ryan-Joiner test (Minitab version 16.1.0). For non-normal data, the best transformation 209 
was identified using a Box-Cox analysis and data were transformed to give a better approximation of 210 
the normal distribution. Means and 95% confidence intervals reported in Table 3, Figure 1 and 211 
Supplementary Table 1 are back-transformed onto the original scale for ease of interpretation. 212 
Further statistical analyses were carried out using SPSS 19. Data were analysed using general linear 213 
model repeated measures ANOVA with appropriate Greenhouse-Geisser corrections for sphericity as 214 
required. For muscle soreness, a Huynh-Feldt correction was applied for the analysis as muscle 215 
soreness was ordinal data (Stiger et al. 1998). Based on the average correlation between repeated 216 
measures of 0.310, we had 80% power to detect an effect size of 0.347 (G*Power v3.1.2). Where a 217 
significant effect was found, posthoc tests were performed using LSD tests. The level of significance 218 
was set at 0.05. 219 
220 
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RESULTS 221 
Baseline Values 222 
There were no significant differences between genotype groups for the baseline values in any 223 
of the indices measured (Table 2). Nor were there any differences in age, height, body mass or body 224 
mass index (BMI) that could have confounded the data. 225 
Immediate Response to Stretch-Shortening Exercise (Bout 1) 226 
As predicted, the stretch-shortening exercise protocol produced measurable levels of muscle 227 
damage immediately after the initial exercise bout (Table 3). This was evidenced by a significant 228 
reduction in muscle function immediately after bout 1 whether measured by voluntary contractions 229 
(MVC and IT, p<0.001 for both; Figures 1A and 1B respectively) or involuntary contractions (P20 230 
and P100, p<0.001 for both; Figure 1D-F). Significant differences in genotype response were 231 
detected for MVC and IT only (timepoint * genotype interaction terms respectively p=0.021 and 232 
p=0.011) with greater reductions in force in the RR group (Figures 1A and 1B respectively). The 233 
angle at which isokinetic peak torque was achieved was not significantly altered immediately after 234 
exercise (Figure 1C). The P20 / P100 ratio was reduced by exercise similarly in both genotype 235 
groups (Figure 1D-F) indicating that the exercise induced low frequency fatigue of similar 236 
magnitude in both genotype groups. 237 
The immediate reductions in muscle function were followed by significant increases in 238 
muscle soreness (p=0.001; Figure 1G) and plasma CK activity (p<0.001; Figure 1H), and a 239 
significant decrease in jump height (p=0.001; Figure 1I). None of the responses differed by genotype 240 
in repeated measures ANOVA. 241 
Timecourse of Stretch-Shortening Exercise Effects (Bout 1) 242 
Peak torque of voluntary and involuntary contractions as well as the P20 / P100 ratio 243 
remained significantly lower than baseline for the duration of the post-exercise bout 1 period 244 
(p<=0.003 for all timepoints; Supplementary Table 1; Figure 1D-F). Muscle soreness (p<0.001), CK 245 
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activity (p<0.001) and jump height (p=0.001) remained significantly different from baseline at 2 246 
days but returned to baseline values by 7 days post exercise (Supplementary Tables 1 and 2; Figures 247 
G-I). The angle at which isokinetic peak torque (p=0.013) was achieved was significantly altered 248 
only 14 days after exercise (Figure 1C). 249 
The jump height, IT and P100 of the XX group returned to baseline values quicker than the 250 
RR values (Supplementary Table 1; Figures 1B, 1D-F and 1I): jump height (p=0.021) and P100 251 
(p=0.003) of the RR group were significantly lower than baseline at day 7 when XX’s had returned 252 
to baseline values (p=0.718 and p=0.136 respectively). However, the SD of the XX group for P100 253 
at day 7 was notably higher than the other days and this may have influenced this result. The IT of 254 
the RR group was significantly reduced from baseline at both days 7 (p=0.001) and 14 (p=0.001) 255 
when XX’s had returned to baseline values (p=0.148 and p=0.199 respectively). The P20 / P100 ratio 256 
was significantly lower than baseline in the XX group (p=0.010) at day 14 when the RR group 257 
(p=0.104) had returned to baseline values. 258 
For MVC, P20 and muscle soreness both genotype groups behaved similarly at all timepoints 259 
after bout 1 (Supplementary Tables 1 and 2; Figures 1A and 1D-F): MVC and P20 remained 260 
significantly reduced in both groups at all timepionts (p<=0.013 for all timepoints in both groups). 261 
Muscle soreness was significantly higher than baseline in both genotype groups at 2 days (RR, 262 
p<0.001 and XX, p=0.001) but returned to baseline values by 7 days.  263 
Repeated Bout Effect (Bout 2) 264 
The repeated bout effect is defined as the phenomenon whereby a second bout of muscle 265 
damaging exercise results in less damage than the intial bout (Clarkson et al. 1992). As expected, this 266 
effect can be seen clearly in the data: reductions in jump height, MVC, IT, P20 and P100 and 267 
increases in muscle soreness and CK activity are either significantly reduced or absent after the 268 
second bout of exercise (Supplementary Tables 1 and 2; Figures 1A-I) and significant interaction 269 
effects for bout * timepoint can be seen for all of these phenoptyes. Similar effects can be seen when 270 
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considering immediate effects of exercise or effects over the entire 2 week timecourse 271 
(Supplementary Tables 1 and 2; Figures 1A-I). None of these effects differed significantly by 272 
genotype. 273 
274 
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DISCUSSION 275 
There are two important findings from this study. Firstly, differences between ACTN3 276 
genotype groups are modest and most easily detected in maximal contractions immediately after 277 
exercise, with XX homozygotes appearing to retain a higher proportion of their baseline voluntary 278 
torque values after stretch shortening exercise. Secondly, XX homozygotes also appear to return to 279 
baseline voluntary torque values faster than RR homozygotes. However, there were no baseline 280 
differences between the genotype groups or differences in their response to the repeated bout of 281 
stretch shortening exercise. 282 
Muscle damage and ACTN3 genotype 283 
The prolonged decrease in muscle force-generating capacity and increased muscle soreness 284 
are consistent with classical muscle damage profiles observed after unaccustomed eccentric exercise 285 
(Byrne et al. 2004). Immediately post-exercise, RR homozygotes had a greater proportional loss of 286 
voluntary contraction torques (MVC and IT) and these reductions took longer to return to baseline 287 
levels. These findings are counter-intuitive and in conflict with our original hypothesis, however, it 288 
should be remembered that much of ACTN3’s function is redundant with ACTN2 and differences 289 
between the ACTN3 genotype groups are perhaps better thought of as differences between ACTN2 290 
and ACTN3 function in fast muscle fibres. Nonetheless, a mechanism that would explain why 291 
homozygosity for the X-allele (i.e. absence of ACTN3) confers better proportional maintenance of 292 
muscle function after stretch-shortening exercise is unknown. 293 
No similar genotype differences were observed in the absolute values or dynamics of the 294 
indirect markers of muscle damage, such as jumping performance or muscle soreness score 295 
suggesting a minor role of alpha-actinin-3 in muscle resistance to exercise induced damage, as 296 
reported by others (Clarkson et al. 2005; McCauley et al. 2009). The lack of differences between 297 
genotypes in involuntary muscular tension in our study could be due to stimulation only evoking 298 
submaximal torques in relation to MVC: the observed tension was only about 50% and 63% of MVC 299 
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during electrical stimulation at 20 Hz and 100 Hz, respectively, in both groups. These are common 300 
values in such types of study, but such stimulation may not be enough to stress the muscle or type II 301 
fibers sufficiently to reveal the difference in intrinsic inotropic state. 302 
In a cross-sectional study of the general U.S. population, female XX homozygotes have 303 
previously been shown to have reduced baseline knee extensor peak torque (Walsh et al. 2008). 304 
Similarly, the actn3 knock out mouse model has reduced grip strength (MacArthur et al. 2008). It is 305 
thus tempting to speculate that XX homozygotes have higher levels of underlying muscle sarcomere 306 
disruption produced by normal daily living and that the extent to which they can increase muscle 307 
damage and impair muscle function further may be limited. Concomitantly, a limited increase in 308 
disruption would allow a return to baseline levels to occur more quickly. Studies involving much 309 
larger numbers of individuals and highly detailed phenotyping would be required to address this 310 
possibility. 311 
Recently, differential binding of Z-disk proteins by ACTN3 and ACTN2 has been 312 
demonstrated in yeast two-hybrid experiments, potentially altering the elastic properties of the 313 
sarcomere (Seto et al. 2011). A desmin-knockout mouse model also provides evidence of reduced 314 
vulnerability to muscle damage (Sam et al. 2000). In R-allele carriers (i.e. with alpha-actinin-3 315 
present), the type II muscle fibers and whole skeletal muscle may generate slightly altered force 316 
transduction along the myofibrils during cross-bridge cycling, provided that the integrity of the 317 
sarcomeres are maintained. Thus alpha-actinin-3 itself may favor more profound Z-line streaming 318 
during intense muscular exertion because of stiffer (compared to XX) thin filament binding. This 319 
may explain our observation of a more pronounced decline in voluntary force production capacity of 320 
RR homozygotes after a bout of drop jumps; RR homozygotes may be more efficient at the expense 321 
of more depressed muscle function and prolonged recovery. 322 
Vincent et al (2010) found a tendency for more pronounced reduction in dynamic concentric 323 
peak torque at high movement speed (200–300°s-1 change in knee angle) in an XX group after a 324 
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single bout of muscle-damaging exercise. However, such high muscle contraction speeds generate 325 
submaximal tension and force production in type II muscle fibers which may account for the 326 
differences observed. They also did not find differences between genotypes in isometric or slow 327 
eccentric peak torques or, in contrast to the present study, in the extent of their decrease after muscle-328 
damaging exercise. These discrepancies could be due to the different protocols used to induce 329 
muscle damage and the different assessments of muscle function. 330 
The repeated bout effect 331 
A protective effect of the initial exercise bout was evidenced by quicker recovery of skeletal 332 
muscle contractile function, less muscle soreness, and lower plasma CK activity after the repeated 333 
bout. Sarcoskeletal alpha-actinins (2 and 3) interact with a diverse range of proteins (Lek et al. 2010) 334 
and these interactions may affect the changes in type II muscle fibers after intense or damaging 335 
exercise. However, the improvement did not differ between genotype groups. On the other hand, it 336 
could be argued that the most important difference was in the length of the recovery period and that 337 
“trainability” may be modulated by ACTN3 genotype through the faster recovery of muscle force in 338 
XX individuals after bout 1. This would allow XX homozygotes to train more frequently, benefiting 339 
their long-term adaptation. However, this is a speculative suggestion and would require confirmation 340 
in a larger study. 341 
To understand the R577X variant, it is important to understand why the X-allele remains so 342 
common in the human population (Mills et al. 2001) and why both the R- and X-alleles appear to 343 
have persisted over such a long evolutionary period (Mills et al. 2001). Although some studies report 344 
an X-allele association with endurance phenotypes, most do not (Alfred et al. 2011) leaving 577X 345 
with no apparent advantage. In this scenario we would expect removal of the 577X allele from the 346 
population and fixation of 577R, which clearly has not occured. From the available data, it may be 347 
that the R-allele confers an advantage in concentric exercise, improving strength performance, whilst 348 
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the X-allele protects against relative loss of function in the days following a bout of exercise 349 
involving eccentric contractions. 350 
In conclusion, homozygosity for the ACTN3 577X allele may reduce the relative functional 351 
loss and provide a faster recovery of functionality to normal levels in response to unaccustomed 352 
plyometric exercise. However, the difference between genotypes is modest and the mechanism by 353 
which the difference is mediated remains elusive. Future studies in this area must involve 354 
significantly larger groups of subjects to ensure sufficient power to investigate what appear to be 355 
subtle differences. 356 
 357 
358 
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TABLES 
Table 1. Study testing protocol 
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Familiarisation session •            
Stretch shortening exercise bout   •     •     
Muscle soreness evaluation Measured daily throughout the study 
Plasma sample for CK activity  •   • • •   • • • 
Muscle functional assessments 
1
  •  • • • •  • • • • 
 
1
 Jump height, maximal voluntary isometric torque, peak concentric isokinetic torque and electrically stimulated knee extension torques at 
20 Hz and at 100 Hz. 
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Table 2. Baseline values of anthopometric measurements, muscle damage and muscle 
function indices. 
 
 RR 
(n=9) 
XX 
(n=8) 
p-value 
(unpaired t-test) 
Age (years)  25.1  1.5  25.8  1.2 0.749 
Height (m) 180.9  1.9 181.7  2.5 0.793 
Body Mass (kg)  77.4  2.4  79.8  4.7 0.649 
BMI (kg∙m-2)  23.7  0.9  24.1  1.0 0.797 
Muscle soreness  0  0  0  0 NA 
CK activity (µkat∙L–1)  2.9  0.7  3.1  0.8 0.897 
Jump height (cm)  40.3  2.5  37.8  2.4 0.486 
MVC (Nm) 292.1  23.9 284.2  19.2 0.802 
IT (Nm) 252.0  17.5 238.3  11.4 0.532 
ITA (degrees) 126.0  2.6 121.9  3.5 0.348 
P20 (Nm) 146.5  10.0 136.5  10.5 0.500 
P100 (Nm) 188.5  15.2 171.3  14.3 0.425 
P20 / P100  0.79  0.029  0.81  0.033 0.658 
 
Values given are mean  standard error of the mean. BMI, body mass index; 
CK, plasma creatine kinase; MVC, maximal voluntary contraction torque; IT, peak 
isokinetic torque; ITA, angle at which IT was acheived; P20, P100, torques evoked by 
20 Hz and 100 Hz electrical stimulation. 
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Table 3. Immediate bout 1 exercise induced changes in muscle damage and muscle function indices for both ACTN3 genotype groups.   
 
 Combined Group 
(n=17) 
p-value
a
 
RR Group 
(n=9) 
p-value
b
 
XX Group 
(n=8) 
p-value
c
 p-value
d
 
Muscle soreness  4.5 (3.4 to 5.6)  <0.001  4.5 (2.8 to 6.3)  <0.001  4.5 (3.1 to 5.8)  <0.001  0.938 
CK activity
†
  72.5 (35.1 to 127.9)  <0.001  72.1 (26.4 to 147.7)  0.008  73.1 (15.3 to 188.4)  0.040  0.983 
Jump height  -6.0 (-8.8 to -3.3)  0.001  -6.6 (-10.6 to -2.6)  0.012  -5.5 (-9.6 to -1.4)  0.035  0.712 
MVC  -29.1 (-33.0 to -25.2)  <0.001  -33.3 (-37.6 to -29.0)  <0.001  -24.5 (-29.7 to -19.2)  <0.001  0.021 
IT  -29.7 (-35.1 to -24.6)  <0.001  -35.9 (-40.4 to -31.8)  <0.001  -23.2 (-31.0 to -16.1)  0.001  0.011 
ITA  -1.7 (-5.8 to 2.1)  0.398  -1.2 (-5.9 to 3.0)  0.595  -2.2 (-9.8 to 4.3)  0.544  0.813 
P20  -65.7 (-69.8 to -61.6)  <0.001  -67.4 (-71.5 to -63.3)  <0.001  -63.8 (-71.4 to -56.2)  <0.001  0.408 
P100  -34.4 (-41.2 to -27.6)  <0.001  -38.0 (-47.3 to -28.6)  <0.001  -30.5 (-40.3 to -20.6)  0.001  0.298 
P20 / P100  -46.5 (-50.9 to -42.4)  <0.001  -45.4 (-52.1 to -39.5)  <0.001  -47.7 (-53.8 to -42.3)  <0.001  0.608 
 
All values are mean change (95% confidence interval) from baseline to immediately post-exercise change as a percentage of 
baseline value except, CK activity and jump height which are baseline to 48 hour change and muscle soreness which is absolute change 
from baseline to 24 hours. CK, plasma creatine kinase; MVC, maximal voluntary contraction torque; IT, peak isokinetic torque; ITA, angle 
at which IT was acheived; P20, P100, torques evoked by 20 Hz and 100 Hz electrical stimulation. 
†
 N-values for RR and XX are 8 and 6 
respectively for CK only. Post-hoc tests are t-tests, other p-values are from repeated measures ANOVAs: 
a
 exercise term, 
b
 Post-hoc 
exercise term for RR group only, 
c
 Post-hoc exercise term for XX group only, 
d
 Interaction between genotype group and exercise term. 
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FIGURES AND LEGENDS 
Fig. 1 (a) Percentage change in MVC, (b) percentage change in IT, (c) percentage 
change in ITA, (d) percentage change in P20, (e) percentage change in P100, (f) 
percentage change in P20 / P100, (g) absolute change in muscle soreness, (h) percentage 
change in plasma CK activity, (i) percentage change in jump height, post-exercise bout 
1 (solid fill; RR ■, and XX ■) and bout 2 (diagonal pattern fill; RR , XX ) in both 
ACTN3 genotype groups. Error bars are SEM. Post-hoc tests are t-tests, other p-
values are from repeated measures ANOVAs: * p<0.05 post hoc compared with 
pre-exercise (paired t-test); ∞ p<0.05 post hoc compared with equivalent 
timepoint and group in bout 1 (paired t-test); # p<0.05 post hoc compared with RR 
at same timepoint and bout (unpaired t-test). 
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